11 | $SONA News Article - Southern National Bancorp of | whytestocks | 10/26/2020 11:55:48 AM |
10 | SONA 12.87 Southern National Bancorp of Virginia | chartguy89 | 12/16/2015 6:38:02 PM |
9 | SONA 12.87 Southern National Bancorp of Virginia | DennyT | 12/16/2015 3:03:01 PM |
8 | SONA Stock year to date has changed +6.61% | Jake13 | 02/27/2015 9:57:19 AM |
7 | SONA 12.09 Southern National Bancorp of Virginia | chartguy89 | 02/27/2015 8:40:00 AM |
6 | SONA Stock year to date has changed +5.73% | Jake13 | 02/26/2015 9:47:28 AM |
5 | SONA 11.99 Southern National Bancorp of Virginia | chartguy89 | 02/26/2015 8:34:06 AM |
4 | SONA Stock year to date has changed +1.23% | Jake13 | 02/14/2015 3:29:49 PM |
3 | SONA 11.48 Southern National Bancorp of Virginia | chartguy89 | 02/14/2015 1:45:03 PM |
2 | Latest Southern National Bancorp of Virginia | Stock_Tracker | 03/13/2014 2:43:45 AM |
1 | SONA Stock Charts Last: +0.139 Thursday, February | chartguy89 | 02/27/2014 10:07:27 AM |
Recent Articles
- Paratus Energy Services Announces Cash Distribution Details
- Aalberts Share Buyback Programme Progress Report Insights
- Viridien Launches Sercel Accel, Transforming Seismic Acquisition
- CROSSJECT Receives Positive Insights and Growth Potential from Maxim
- Aedifica and Cofinimmo: The Rise of Europe's Healthcare REIT
- Paratus Energy Services Announces Ex Cash Distribution Details
- Innovative Kepler K2 'Bumblebee' Thrills Robotics Event Attendees
- Enhancing Home Safety: Insights from Hanover's Report
- Veriff Unveils Enhanced AI Proof of Address for KYC Efficiency
- argenx to Engage with Investors at Prestigious Healthcare Event
- Rilzabrutinib's Orphan Drug Designation: A Breakthrough for Sickle Cell
- Roche's Tecentriq and Lurbinectedin Transform ES-SCLC Outcomes
- Addex Therapeutics 2025 Annual General Meeting Details Revealed
- Collaborative Innovations in Plastics Recycling for Construction
- dsm-firmenich's Commitment to Shareholder Value Through Buybacks
- Exciting Insights from TGS at the EAGE Conference
- Elevate Your Workspace with Baseus' 12-in-1 Docking Station
- Tianjin's Commitment to Elevating Workforce Skills
- FIFA Faces Growing Pressure to End Partnership with Coca-Cola
- FIFA Faces Calls to End Partnership with Coca-Cola Amid Health Concerns
- Silicon Labs and Wirepas Revolutionizing Industrial IoT Solutions
- Exciting Conclusion of the Taklimakan Rally 2025: A Race to Remember
- Envision Energy and Marubeni Forge Path for Green Ammonia
- Innovative Solutions for Caregiver Burnout by Caily
- Envision Energy Teams Up with Marubeni for Sustainable Future
- Innovative Partnership to Introduce Sustainable Biosurfactants
- Arctech's Five-Year Journey in Solar Innovation and Growth
- Nutex Health Shares Details for Virtual Annual Meeting Access
- Explore Your Rights: Join Iovance Biotherapeutics Class Action
- China's Journey to Technological Prowess and Global Contributions
- Univest Securities, LLC Takes Center Stage at Japan GO IPO Summit
- Jenscare Unveils Groundbreaking Results from Recent Studies
- Innovative Treatment Shows Promise for Advanced Gastric Cancer
- Innovent Biologics Advances IBI354 for Cancer Treatment
- Innovent Biologics Unveils Promising Phase 1 Results for IBI343
- Innovative MEA System by Sony, SCREEN, and VitroVo Launches
- Transformative Advances in CNS Cell Therapy by XellSmart
- Trust3 AI Emerges as a Leader in Trusted AI Solutions
- Bella Sun Luci Expands Internationally at Gulfood Expo
- Extendicare Expands Care with Purchase of Nine Facilities
- Celebrating Exchange: BridgeUSA Tour Enhancing Cultural Ties and Economy
- Cognizant Honored for Excellence in AI-Powered Transformations
- EVA Air Enhances Flight Safety Through IATA Partnership
- How AI is Transforming the Financial Services Landscape
- MY DR NOW Expands Footprint with New Clinic Opening
- Investors Eye Open Lending Corporation Legal Action for Justice
- Atlas Ocean Voyages Introduces Exclusive Expedition Offer
- Semilux's Path to Compliance Following Nasdaq Notification
- DeFi Development Corp. Achieves Exceptional Growth in May 2025
- Nxera Pharma Secures $15 Million from Neurocrine's Advancement